These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6960190)

  • 1. Hepatic encephalopathy.
    Davidoff S; Werbitt W
    J Med Soc N J; 1982 Nov; 79(12):919-22. PubMed ID: 6960190
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].
    Blanc P; Daurès JP; Liautard J; Buttigieg R; Desprez D; Pageaux G; Allaz JL; Parelon G; Larrey D; Michel H
    Gastroenterol Clin Biol; 1994; 18(12):1063-8. PubMed ID: 7750678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
    Als-Nielsen BE; Gluud LL; Gluud CN
    Ugeskr Laeger; 2005 Jan; 167(2):179-82. PubMed ID: 15697132
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent acquisitions in the treatment and pathogenesis of hepatic coma].
    Casciani CU; Ancarani E
    Recenti Prog Med; 1977 Aug; 63(2):196-211. PubMed ID: 579260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
    Doffoël M; Vetter D
    Gastroenterol Clin Biol; 1994; 18(12):1055-6. PubMed ID: 7750676
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dilemmas of clinical experimentation: use of lactulose in portocaval encephalopathy].
    Conn HO
    Union Med Can; 1974 Dec; 103(12):2058-60. PubMed ID: 4619236
    [No Abstract]   [Full Text] [Related]  

  • 10. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
    Juttijudata P; Meensook C
    J Med Assoc Thai; 1981 Dec; 64(12):636-9. PubMed ID: 6153032
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode.
    Mann NS; Borkar BB; Narenderan KP; Kadian RS; Mann SK; Martin RL
    Am J Gastroenterol; 1979 Aug; 72(2):141-5. PubMed ID: 38663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R
    Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.
    Orlandi F; Freddara U; Candelaresi MT; Morettini A; Corazza GR; Di Simone A; Dobrilla G; Cavallini G
    Dig Dis Sci; 1981 Jun; 26(6):498-506. PubMed ID: 7016484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
    Capocaccia L; Riggio O
    Hepatology; 1990 Aug; 12(2):368-70. PubMed ID: 2391075
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exogenous hepatic coma--standard therapy with amino acid solutions].
    Bode JC; Reiter HJ
    Beitr Infusionther Klin Ernahr; 1979; (4):49-62. PubMed ID: 399584
    [No Abstract]   [Full Text] [Related]  

  • 18. Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
    Van Der Zwan JC; Gips CH; Qué GS; Boonstra S
    Neth J Med; 1974; 17(2):42-9. PubMed ID: 4839373
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognition and management of acute and chronic hepatic encephalopathy.
    Jacobson S; Bell B
    Med Clin North Am; 1973 Nov; 57(6):1569-77. PubMed ID: 4583596
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.